Nasopharyngeal carcinoma: relationship between 18F-FDG PET-CT maximum standardized uptake value, metabolic tumour volume and total lesion glycolysis and TNM classification

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Nuclear medicine communications

• Publication date

  2010-03-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/MNM.0b013e328333e3efPMID 19966594
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• 18F-FDG PET/CT as an Indicator of Progression-Free and Overall Survival in Osteosarcoma

  2009cited by this paper
• Prediction for distant failure in patients with stage M0 nasopharyngeal carcinoma: the role of standardized uptake value.

  2009cited by this paper
• Determination of whole-body metabolic burden as a quantitative measure of disease activity in lymphoma: a novel approach with fluorodeoxyglucose-PET

  2008cited by this paper
• Prediction of prognosis using standardized uptake value of 2-[(18)F] fluoro-2-deoxy-d-glucose positron emission tomography for nasopharyngeal carcinomas.

  2008cited by this paper
• Correlation of positron emission tomography standard uptake value and pathologic specimen size in cancer of the head and neck.

  2008cited by this paper
• Adenocarcinomas of the esophagus: response to chemoradiotherapy is associated with decrease of metabolic tumor volume as measured on PET-CT. Comparison to histopathologic and clinical response evaluation.

  2008cited by this paper
• Primary tumor volume calculation as a predictive factor of prognosis in nasopharyngeal carcinoma

  2008cited by this paper
• Primary tumor volume of nasopharyngeal carcinoma: prognostic significance for recurrence and survival rate

  2008cited by this paper
• Secular trends of nasopharyngeal carcinoma incidence in Singapore, Hong Kong and Los Angeles Chinese populations, 1973–1997

  2007cited by this paper
• 18F-FDG PET Can Replace Conventional Work-up in Primary M Staging of Nonkeratinizing Nasopharyngeal Carcinoma

  2007cited by this paper
• Pretreatment F-18 Fluorodeoxyglucose-positron Emission Tomography Standardized Uptake Value Predicts Survival After Radiation Therapy in Nasopharyngeal Carcinoma

  2007cited by this paper
• Fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography imaging in patients with carcinoma of the nasopharynx: diagnostic accuracy and impact on clinical management.

  2007cited by this paper
• Influence of FDG-PET on computed tomography-based radiotherapy planning for locally recurrent nasopharyngeal carcinoma.

  2007cited by this paper
• The management of neck metastases in nasopharyngeal cancer

  2007cited by this paper
• Management of Neck Metastases of Nasopharyngeal Carcinoma

  2007cited by this paper
• AJCC cancer staging atlas

  2006cited by this paper
• Correlation between MR imaging-derived nasopharyngeal carcinoma tumor volume and TNM system.

  2006cited by this paper
• Relationship between pretreatment level of plasma Epstein-Barr virus DNA, tumor burden, and metabolic activity in advanced nasopharyngeal carcinoma.

  2006cited by this paper
• The relationship between nasopharyngeal carcinoma tumor volume and TNM T-classification: a quantitative analysis

  2006cited by this paper
• Lymphatic vessels in cancer metastasis: bridging the gaps.

  2006cited by this paper
• State-of-the-art management of nasopharyngeal carcinoma: current and future directions

  2005cited by this paper
• Tumor volume in pharyngolaryngeal squamous cell carcinoma: comparison at CT, MR imaging, and FDG PET and validation with surgical specimen.

  2004cited by this paper
• Better prediction of prognosis for patients with nasopharyngeal carcinoma using primary tumor volume

  2004cited by this paper
• Primary tumor volume of nasopharyngeal carcinoma: prognostic significance for local control.

  2004cited by this paper
• Sequential preoperative fluorodeoxyglucose-positron emission tomography assessment of response to preoperative chemoradiation: a means for determining longterm outcomes of rectal cancer.

  2004cited by this paper
• Insights into the mechanisms of lymph node metastasis

  2003cited by this paper
• Nasopharynx: clinical, pathologic, and radiologic assessment.

  2003cited by this paper
• Radiation treatment planning with an integrated positron emission and computer tomography (PET/CT): a feasibility study.

  2003cited by this paper
• 18‐Fluoro‐2‐deoxyglucose positron emission tomography in detecting residual/recurrent nasopharyngeal carcinomas and comparison with magnetic resonance imaging

  2003cited by this paper
• Cancer spread and micrometastasis development: Quantitative approaches for in vivo models

  2002cited by this paper
• FDG-PET for prediction of tumour aggressiveness and response to intra-arterial chemotherapy and radiotherapy in head and neck cancer

  2002cited by this paper
• The predictive value of the 1997 American Joint Committee on Cancer stage classification in determining failure patterns in nasopharyngeal carcinoma

  2001cited by this paper
• Comparison of 18-Fluoro-2-Deoxyglucose Positron Emission Tomography and Computed Tomography in Detection of Cervical Lymph Node Metastases of Nasopharyngeal Carcinoma

  2000cited by this paper
• Tumor Treatment Response Based on Visual and Quantitative Changes in Global Tumor Glycolysis Using PET-FDG Imaging. The Visual Response Score and the Change in Total Lesion Glycolysis.

  1999cited by this paper
• Prediction of survival with fluorine-18-fluoro-deoxyglucose and PET in head and neck cancer.

  1997cited by this paper
• How cancer spreads.

  1996cited by this paper
• Seminars in Medicine of the Beth Israel Hospital, Boston. Clinical applications of research on angiogenesis.

  1995cited by this paper
• Clinical Applications of Research on Angiogenesis

  1995cited by this paper

• Feasibility analysis of metabolic parameters based on baseline 18F-FDG PET/CT to predict heterogeneity and recurrence of diffuse large B-cell lymphoma

  2025cites this paper
• Critères d’évaluation de la TEP au 18F-FDG au cours de l’immunothérapie

  2024cites this paper
• Prognostic value of primary tumor and lymph node volumetric metabolic parameters at pre-treatment F-18 FDG PET/CT in nasopharyngeal carcinoma.

  2023cites this paper
• Deep learning techniques in PET/CT imaging: A comprehensive review from sinogram to image space

  2023cites this paper
• Valor pronóstico de los parámetros metabólicos volumétricos del tumor primario y ganglios linfáticos en el PET/TC pretratamiento en el carcinoma nasofaríngeo

  2023cites this paper
• Correlation between Tissue Cellularity and Metabolism Represented by Diffusion-Weighted Imaging (DWI) and 18F-FDG PET/MRI in Head and Neck Cancer (HNC)

  2022cites this paper
• The valuable role of dynamic 18F FDG PET/CT-derived kinetic parameter Ki in patients with nasopharyngeal carcinoma prior to radiotherapy: a prospective study.

  2022cites this paper
• Focal Nasopharyngeal Activity Detected on [18F]FDG PET/CT: Clinical Implications and Comparison of Metabolic Parameters for Prediction of Malignancy

  2022cites this paper
• Survival effect of pretreatment FDG-PET-CT on nasopharyngeal cancer.

  2022cites this paper
• Association Between Diffusion Weighted-Imaging (DWI) and Simultaneous 18F-FDG-PET/MRI Parameters with a Comparison of their Diagnostical Role in Head and Neck Squamous Cell Carcinoma (HNSCC)

  2021cites this paper
• Prognostic value of tumor metabolic imaging phenotype by FDG PET radiomics in HNSCC

  2021cites this paper
• [18F] FDG PET/CT and Head and Neck MRI in the Diagnosis and Prognosis of Moroccan Patients With Nasopharyngeal Carcinoma

  2021cites this paper
• Assessment of biological and clinical aggressiveness of invasive ductal breast cancer using baseline 18F-FDG PET/CT-derived volumetric parameters

  2018cites this paper
• Can diffusion weighted magnetic resonance imaging (DW-MRI) be an alternative to 18f-FDG PET/CT (18f fluorodeoxyglucose positron emission tomography) in nasopharyngeal cancers?

  2017cites this paper
• Prognostic value of maximum standard uptake value, metabolic tumor volume, and total lesion glycolysis of positron emission tomography/computed tomography in patients with nasopharyngeal carcinoma

  2017cites this paper
• Automatic image quantification strategies in clinical nuclear medicine and neuroradiology

  2017cites this paper
• Evaluation of Time-Phase Effect on 18F-FDG PET/CT Delineation Methods for Treatment Planning of Nasopharyngeal Carcinoma

  2016cites this paper
• [18F]FDG-PET/CT metabolic parameters as useful prognostic factors in cervical cancer patients treated with chemo-radiotherapy

  2016cites this paper
• The Clinical Usefulness of 18F-Fluorodeoxyglucose Positron Emission Tomography (PET) to Predict Oncologic Outcomes and PET-Based Radiotherapeutic Considerations in Locally Advanced Nasopharyngeal Carcinoma

  2015cites this paper
• Deriving global quantitative tumor response parameters from 18F-FDG PET-CT scans in patients with non-Hodgkin’s lymphoma

  2015cites this paper
• Burkitt lymphoma classification and MYC-associated non-Burkitt lymphoma investigation based on gene expression

  2015cites this paper
• FDG PET/CT in the management of nasopharyngeal carcinoma.

  2014cites this paper
• Obtaining quantitative global tumoral state indicators based on whole-body PET/CT scans: a breast cancer case study

  2014cites this paper
• Clinical application value and progress of PET/CT in nasopharyngeal carcinoma

  2014cites this paper
• Three-dimensional positron emission tomography image texture analysis of esophageal squamous cell carcinoma: relationship between tumor 18F-fluorodeoxyglucose uptake heterogeneity, maximum standardized uptake value, and tumor stage

  2013cites this paper
• Accuracy of whole-body FDG-PET and FDG-PET/CT in M staging of nasopharyngeal carcinoma: a systematic review and meta-analysis.

  2013cites this paper
• The relationship between 18F-FDG metabolic volumetric parameters and clinicopathological factors of breast cancer

  2013cites this paper
• Clinical implications of initial FDG-PET/CT in locally advanced rectal cancer treated with neoadjuvant chemoradiotherapy

  2013cites this paper
• Oesophageal squamous cell carcinoma: relationship between fluorine-18 fludeoxyglucose positron emission tomography CT maximum standardised uptake value, metabolic tumour volume, and tumour, node and metastasis classification.

  2012influential citation
• Nasopharyngeal carcinoma: investigation of intratumoral heterogeneity with FDG PET/CT.

  2012cites this paper
• Dynamic PET-CT studies for characterizing nasopharyngeal carcinoma metabolism: comparison of analytical methods

  2012cites this paper
• Multimodal treatment, including interferon beta, of nasopharyngeal carcinoma in children and young adults

  2012cites this paper
• Prognostic Significance of Volume-Based PET Parameters in Cancer Patients

  2012cites this paper
• Experimental model of naturally occurring post-radiation sarcoma: interest of positron emission tomography (PET) for early detection.

  2012cites this paper
• Image-Derived Arterial Input Function in Dynamic Positron Emission Tomography–Computed Tomography: A Method Using Both Positron Emission Tomographic and Computed Tomographic Images

  2012cites this paper
• Prognostic Significance of Volume-Based Metabolic Parameters in Uterine Cervical Cancer Determined Using 18F-Fluorodeoxyglucose Positron Emission Tomography

  2012cites this paper
• Prognostic value of quantitative parameters derived on initial staging 18F-fluorodeoxyglucose positron emission tomography/computed tomography in patients with high-grade non-Hodgkin’s lymphoma

  2012cites this paper
• Prognostic Impact of Standardized Uptake Value of F-18 FDG PET/CT in Nasopharyngeal Carcinoma

  2011cites this paper